Skip to content
TrustList
BC
Investor

Brandon Capital's Medical Research Commercialisation Fund

Life science investment collaboration in Australia and New Zealand, now called Brandon BioCatalyst

Write a review
Visit WebsiteGet introducedWrite a Review
Own this listing? Claim it
Brandon Capital's Medical Research Commercialisation Fund cover

About Brandon Capital's Medical Research Commercialisation Fund

Brandon Capital's Medical Research Commercialisation Fund, or MRCF, is a life science investment collaboration for Australia and New Zealand. In 2022 it was renamed Brandon BioCatalyst. It is managed by Brandon Capital, a life science venture investor.

What the fund does

  • Early to expansion funding: supports life science companies from proof of concept through to commercialisation.
  • Translation expertise: Brandon Capital guides research discoveries towards commercial products.
  • Co-investment capacity: investors can invest alongside the funds, giving extra room to support portfolio companies.

Customers and markets

The collaboration links more than 50 medical research institutes and hospitals in Australia and New Zealand with superannuation funds and government bodies. Investors and venture partners come from Australia, New Zealand, the United States and the United Kingdom. The aim is to turn promising discoveries into new treatments and better patient outcomes.

Key facts

  • Founded: 2007, in Melbourne
  • Founders: Chris Nave, Stephen Thompson and David Fisher
  • Portfolio: helped form and fund over 50 life science companies
  • Offices: Australia, New Zealand, London and San Francisco

Profile written by TrustList from the business's own published information, Oct 2026.

Categories & features

Rankings

As of 2026-10-29. Organic ranks only; sponsored placements are never ranks.

What the business tells TrustList

Founded
2007 (19 years) evidence sent

Ask TrustList to introduce you to Brandon Capital's Medical Research Commercialisation Fund

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Brandon Capital's Medical Research Commercialisation Fund

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Brandon Capital's Medical Research Commercialisation Fund.

Brandon Capital's Medical Research Commercialisation Fund alternatives

Similar listings buyers compare against this one.

Compare side by side
Future Labs logo

Future Labs

Network of New York City business incubators and accelerators run through NYU Tandon for early-stage ventures

Kurma Partners logo

Kurma Partners

European venture firm funding healthcare and biotechnology companies from creation to expansion

Crypto.com Capital logo

Crypto.com Capital

Venture arm of a crypto exchange group investing in early-stage Web3 and crypto start-ups

MPM Capital logo

MPM Capital

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Lumira Ventures logo

Lumira Ventures

Life sciences venture firm working with entrepreneurs to build healthcare and drug-development companies

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.